Botulinum toxin type A in the treatment of patients with cervical dystonia.
Dystonia is an involuntary movement involving twisting and turning of agonist and antagonist muscles. Cervical dystonia is isolated to neck musculature. Botulinum toxin type A is a safe and effective treatment of this disabling and often painful syndrome. Three forms of botulinum toxin type A are available worldwide to treat patients with cervical dystonia. This is a review of the studies of botulinum toxin type A to treat cervical dystonia.
Brashear
Allison
A
Dept of Neurology, Wake Forest University Baptist, Medical Center, Winston Salem, NC, USA. abrashea@wfubmc.edu
Eur Neurol. 2002;47(2):118-21
11844901
Neurologist. 2008 Sep;14(5):289-98
18784598
Muscle Nerve Suppl. 1997;6:S146-68
9826987
Neurology. 2005 Nov 8;65(9):1423-9
16275831
Mov Disord. 2000 Jan;15(1):150-3
10634256
Neurology. 1989 Jan;39(1):80-4
2642616
Neurology. 1990 Feb;40(2):277-80
2300249
Mov Disord. 2004 Mar;19(3):303-8
15022184
Mov Disord. 1994 Mar;9(2):213-7
8196686
J Neurosurg. 2002 Sep;97(2 Suppl):207-12
12296680
Mov Disord. 2001 Nov;16(6):1086-90
11748739
Neurology. 2008 May 6;70(19):1699-706
18458230
Neurology. 1991 Jul;41(7):1088-91
2067638
N Engl J Med. 2006 Nov 9;355(19):1978-90
17093249
Semin Neurol. 2001;21(1):85-90
11346029
Clin Neuropharmacol. 2000 Sep-Oct;23(5):239-51
11154091
Neurology. 1998 Jun;50(6):1624-9
9633703
Expert Opin Drug Saf. 2005 Mar;4(2):241-9
15794717
Mov Disord. 2008 Jul 30;23(10):1353-60
18546321
Mayo Clin Proc. 1991 Apr;66(4):433-5
2013994
Lancet Neurol. 2006 Sep;5(9):780-90
16914406
Neurology. 1990 Aug;40(8):1213-8
2199847
Neurology. 1996 Apr;46(4):1066-72
8780093
Trans Am Ophthalmol Soc. 1989;87:174-80; discussion 180-4
2562519
Clin J Pain. 2002 Nov-Dec;18(6 Suppl):S119-24
12569958
J Neurosci. 2002 Feb 15;22(4):1350-62
11850462
J Neurol Neurosurg Psychiatry. 1998 Jan;64(1):13-7
9436721
Neurology. 2003 Apr 8;60(7):1186-8
12682332
Mov Disord. 1993 Oct;8(4):479-83
8232357
Adv Neurol. 1998;78:1-10
9750897
Muscle Nerve. 1994 Dec;17(12):1385-92
7969239
Neurology. 1999 Oct 22;53(7):1439-46
10534248
Neurology. 1999 Oct 22;53(7):1431-8
10534247
Neurology. 2006 Dec 26;67(12):2233-5
17190952
Adv Neurol. 1988;50:361-5
3400496
Ophthalmology. 1985 May;92(5):676-83
4011142
J Neurol. 2001 Dec;248(12):1073-8
12013585
Neurology. 1992 Apr;42(4):878-82
1565246
J Neurol Neurosurg Psychiatry. 1990 Aug;53(8):640-3
2213040
J Neurol Neurosurg Psychiatry. 1998 Jan;64(1):6-12
9436720
Neurology. 2007 Feb 6;68(6):457-9
17283323
Neurology. 1997 Sep;49(3):701-7
9305326
J Neurol Neurosurg Psychiatry. 1998 May;64(5):577-80
9598669
Neurology. 2005 Jun 14;64(11):1949-51
15955951
Mov Disord. 2005 Jul;20(7):783-91
15736159
Biochim Biophys Acta. 1970 Aug 21;214(2):343-9
4993506
J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):459-62
11909903
Neurology. 1998 Sep;51(3):815-9
9748032
Muscle Nerve Suppl. 1997;6:S129-45
9826986
Neurology. 2000;55(12 Suppl 5):S9-14
11188983
J Physiol. 1949 Aug;109(1-2):10-24
15394302
J Neurol Neurosurg Psychiatry. 1999 May;66(5):612-6
10209172
Eur J Neurol. 2006 Dec;13 Suppl 4:20-6
17112346
Neurology. 2000;55(12 Suppl 5):S22-8
11188981